- Request for follow-up
- Medical Information
- Other Information
Congress Publications
For Information on past and upcoming Medical Congresses in which argenx is presenting clincial research and data, please select the disease area of interest
ITP
International Society on Thrombosis and Haemostasias (ISTH)
June 24-28, 2023
-
Montreal, Canada
International Society on Thrombosis and Haemostasias (ISTH)
June 24-28, 2023
-
Montreal, Canada
- PRESENTATION: Time course of treatment-related adverse events (TRAEs) during dostarlimab therapy in the GARNET trial dostarlimab
- PRESENTATION: Biomarker correlates of response in patients with advanced Myxoid/Round Cell Liposarcoma (MRCLS) treated with NY-ES0-1 TCR T cells (Letetresgene autolueucel)
European Hematology Association (EHA)
June 8-11, 2023
-
Frankfurt, Germany
European Hematology Association (EHA)
June 8-11, 2023
-
Frankfurt, Germany
- PRESENTATION: Time course of treatment-related adverse events (TRAEs) during dostarlimab therapy in the GARNET trial dostarlimab
- PRESENTATION: Biomarker correlates of response in patients with advanced Myxoid/Round Cell Liposarcoma (MRCLS) treated with NY-ES0-1 TCR T cells (Letetresgene autolueucel)
American Society of Hematology (ASH)
December 10-13, 2022
-
New Orleans, LA
American Society of Hematology (ASH)
December 10-13, 2022
-
New Orleans, LA
- PRESENTATION: Time course of treatment-related adverse events (TRAEs) during dostarlimab therapy in the GARNET trial dostarlimab
- PRESENTATION: Biomarker correlates of response in patients with advanced Myxoid/Round Cell Liposarcoma (MRCLS) treated with NY-ES0-1 TCR T cells (Letetresgene autolueucel)
